Literature DB >> 15619018

Duodenal somatostatinoma associated with Von Recklinghausen's disease.

Volker Fendrich1, Annette Ramaswamy, Emily P Slater, Detlef K Bartsch.   

Abstract

Somatostatinomas are rare, malignant, somatostatin-producing neuroendocrine tumors with a prevalence of one in 40 million. The coincidence of Von Recklinghausen's disease and duodenal somatostatinoma has been known since 1982. We report the case of a 57-year-old female patient with Von Recklinghausen's disease and a tumor of the pancreatic head that was diagnosed due to painless icterus. Histopathological examination after pylorus-preserving pancreatoduodenectomy revealed the existence of a duodenal somatostatinoma with lymph node metastases. Characteristics of the association of von Recklinghausen's disease and somatostatinoma, and therapy and prognosis will be discussed. In patients with Von Recklinghausen's disease and an ampullary tumor, a somatostatinoma should be considered. In contrast to its pancreatic counterparts, duodenal somatostatinoma is frequently associated with Von Recklinghausen's disease, often contains psammoma bodies, is rarely associated with a recognizable "somatostatin syndrome", and is hardly ever associated with demonstrable metastases at the time of diagnosis. Small tumors arising in the duodenum may be treated with local excision, whereas larger tumors should be treated by total excision, which may entail a partial pancreatoduodenectomy.

Entities:  

Mesh:

Year:  2004        PMID: 15619018     DOI: 10.1007/s00534-004-0918-3

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  5 in total

Review 1.  Duodenal somatostatinoma presenting as obstructive jaundice with the coexistence of a gastrointestinal stromal tumour in neurofibromatosis type 1: a case with review of the literature.

Authors:  Subhanudh Thavaraputta; Suzanne Graham; Ana M Rivas Mejia; Joaquin Lado-Abeal
Journal:  BMJ Case Rep       Date:  2019-01-10

Review 2.  Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.

Authors:  Daniel Relles; Jennie Baek; Agnieszka Witkiewicz; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

Review 3.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09

Review 4.  Gl-NETs-uniform but also diverse.

Authors:  Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

5.  Neuroendocrine tumour in a patient with neurofibromatosis type 1 and HIV.

Authors:  Juliane Hiesgen; Ebrahim Variava
Journal:  South Afr J HIV Med       Date:  2015-06-26       Impact factor: 2.744

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.